TSLA Trades at a 2.3% Discount to the Underlying Stock, Backed by the Sparks Semi Launch and a 2500-Unit Fleet Order

• • \TSLA instrument now trades around $334, while Tesla just began high-volume Semi truck production at its new Sparks, Nevada plant.
• • ZET SCALE ordered 2500 Tesla Semi units as an initial order from a stated plan of over 10000 units, while UBS maintained a Neutral rating with a $385 price target.

Tesla (TSLA) stock picked up several new fundamental catalysts: Tesla began high-volume production and initial deliveries of its electric Semi truck at its new Sparks, Nevada plant (facility spans roughly 1.7 million square feet, capacity up to 50000 units per year), with the Long Range trim claiming 500 miles per charge and a listed price of $290000. ZET SCALE selected Tesla as its primary OEM for an initial order of 2500 Semi units, with plans for a total order of over 10000 electric trucks from multiple providers. On the other side, UBS estimates Tesla's Q3 deliveries at roughly 470000 units, down 5 percent year-over-year and about 1 percent below Q2, though still near the midpoint of external forecasts - UBS maintained a Neutral rating with a $385 price target, which the firm notes is already near Tesla's current trading level. As an added risk, Belgian FSD testing over roughly 400 km found repeated speed-limit errors, including exceeding the 20 km/h limit in 42 percent of residential areas. This tokenized TSLA instrument now trades at $334.31 (CoinMarketCap, today), slightly below the $342.34 reference TSLA stock price (CoinGecko Stocks) - a discount of roughly 2.3 percent, unusual for a 1:1-backed instrument and one that could narrow as the Semi production ramp and this large fleet order are absorbed by the market. The first target is $343 (Rp6102614), about 2.5 percent above entry, within 3 days - this level closes the discount to the reference stock price - with a second target at $355 (Rp6318290), about 6.1 percent above entry.

UBS's Neutral rating with a $385 target suggests analysts see limited upside from current levels, and the 5 percent YoY drop in projected Q3 deliveries points to ongoing demand pressure. The Belgian FSD test findings also add near-term regulatory/reputational risk. This scenario is void if price breaks below $320 (Rp5695360).